A recent open-label trial evaluated the safety and efficacy of 60 mg/day of pantethine in fifteen children with PKAN for twenty-four weeks [47]
10.4 When will I start noticing results from CJC-1295 and ipamorelin
Why Sermorelin Has a Favorable Long-Term Profile Several pharmacological characteristics contribute to sermorelins safety over time: Self-regulating mechanism: The hypothalamic-pituitary feedback loop prevents excessive GH accumulation Pulsatile release pattern: Mimics natural physiology rather than creating sustained supraphysiological levels No exogenous hormone: The body produces its own GH, maintaining receptor sensitivity No suppression of endogenous production: Unlike exogenous HGH, sermorelin does not suppress the pituitarys own GHRH responsiveness Long-Term Monitoring Recommendations For patients on extended sermorelin protocols, recommended monitoring includes: IGF-1 levels: Checked every 3-6 months to ensure levels remain within normal ranges (typically targeting the upper third of the age-adjusted reference range) Fasting glucose and HbA1c: GH can influence insulin sensitivity
Possible disagreements were resolved in a panel discussion
The body appears to develop some tolerance to the GI effects with consistent exposure
Amitani, M., Asakawa, A., Amitani, H